Hikma Pharmaceuticals PLC (DE:H5P)
FRANKFURT:H5P
H5P Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
H5P Stock 12 Month Forecast
Average Price Target
€21.21
▲(18.49% Upside)
| Highest Price Target€21.61 | Average Price Target€21.21 | Lowest Price Target€20.80 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Jefferies
€21.38→€21.61
Buy
20.75%
Upside
Reiterated
05/05/26
Berenberg Bank
€20.8
Buy
16.23%
Upside
Assigned
04/28/26
J.P. Morgan
€23.12
Buy
29.14%
Upside
Reiterated
03/03/26
Barclays
€15.6
Sell
-12.83%
Downside
Reiterated
03/02/26
Deutsche Bank
€28.9→€27.74
Buy
54.97%
Upside
Reiterated
01/09/26
RBC Capital
€30.34
Buy
69.50%
Upside
Reiterated
08/11/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
€21.38→€21.61
Buy
20.75%
Upside
Reiterated
05/05/26
Berenberg Bank
€20.8
Buy
16.23%
Upside
Assigned
04/28/26
J.P. Morgan
€23.12
Buy
29.14%
Upside
Reiterated
03/03/26
Barclays
€15.6
Sell
-12.83%
Downside
Reiterated
03/02/26
Deutsche Bank
€28.9→€27.74
Buy
54.97%
Upside
Reiterated
01/09/26
RBC Capital
€30.34
Buy
69.50%
Upside
Reiterated
08/11/25
Best Analysts Covering Hikma Pharmaceuticals
3 Months
Success Rate
7/15 ratings generated profit
Average Return
+0.36%
Copying James Vane's trades and holding each position for 3 Months would result in 46.67% of your transactions generating a profit, with an average return of +0.36% per trade.
1 Year
Success Rate
5/15 ratings generated profit
Average Return
-7.81%
Copying James Vane's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -7.81% per trade.
2 Years
Success Rate
5/15 ratings generated profit
Average Return
-4.36%
Copying James Vane's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -4.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
H5P Analyst Recommendation Trends
Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
1
2
1
1
0
Buy
1
2
2
3
2
Hold
0
0
0
0
0
Sell
1
2
1
1
0
Strong Sell
0
0
0
0
0
total
3
6
4
5
2
Each month's total comprises the sum of three months' worth of ratings.
H5P Financial Forecast
H5P Stock Forecast FAQ
What is DE:H5P’s average 12-month price target, according to analysts?
Based on analyst ratings, Hikma Pharmaceuticals PLC’s 12-month average price target is 21.21.
What is DE:H5P’s upside potential, based on the analysts’ average price target?
Hikma Pharmaceuticals PLC has 18.49% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Hikma Pharmaceuticals PLC a Buy, Sell or Hold?
Hikma Pharmaceuticals PLC has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Hikma Pharmaceuticals PLC’s share price target?
The average share price target for Hikma Pharmaceuticals PLC is 21.21. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €21.61 ,and the lowest forecast is €20.80. The average share price target represents 18.49% Increase from the current price of €17.9.
The highest analyst share price target is €21.61 ,and the lowest forecast is €20.80. The average share price target represents 18.49% Increase from the current price of €17.9.
What do analysts say about Hikma Pharmaceuticals PLC?
Hikma Pharmaceuticals PLC’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Hikma Pharmaceuticals PLC?
To buy shares of DE:H5P, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.